Desktop Site
|
18 Apr 24 | 16:00
|
Close
Equity
SME
Eq Drv
Currency
Commodity
Corporates
Get Quote
Notices
|
S&P
BSE SENSEX
72,488.99
-454.69
-0.62 %
Corporate Announcement
Security Code
506197
Company
Bliss GVS Pharma Ltd
Exchange Received Time
02/11/2019 20:02:45
Exchange Disseminated Time
02/11/2019 20:02:52
Time Taken
00:00:07
Board Meeting Intimation for Board Meeting Intimation For Consideration And Approval Of The Unaudited Standalone And Consolidated Financial Results For The Quarter And Half Year Ended September 30, 2019 |
11/02/19 20:02
BLISS GVS PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/11/2019 ,inter alia, to consider and approve Pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended, we wish to inform you that the Board Meeting of the Company will be held on Monday, November 11, 2019, inter alia, to consider and approve the Un-audited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended September 30, 2019.
Further, pursuant to SEBI (Prohibition of Insider Trading) (Amendment) Regulations, 2018, the trading window for dealing in shares of the Company was closed for all the Designated Persons and their immediate relatives of the Company from October 1, 2019 and shall remain closed till 48 hours after the announcement of the Financial Results i.e. up to Wednesday, November 13, 2019.
Kindly acknowledge and take on record the same.
Attachment
<< Back
Recently Viewed